Literature DB >> 4022545

Enteric administration of anisodamine in the treatment of hemorrhagic shock.

J Y Su, C E Hock, A M Lefer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4022545     DOI: 10.1007/bf02888634

Source DB:  PubMed          Journal:  Acta Acad Med Wuhan        ISSN: 0253-3316


× No keyword cloud information.
  8 in total

1.  Pancreatic hydrolases and the formation of a myocardial depressant factor in shock.

Authors:  A M Lefer; Y Barenholz
Journal:  Am J Physiol       Date:  1972-11

2.  Relationship of plasma peptides to the myocardial depressant factor in hemorrhagic shock in cats.

Authors:  A M Lefer; J Martin
Journal:  Circ Res       Date:  1970-01       Impact factor: 17.367

3.  Anisodamine in treatment of some diseases with manifestations of acute microcirculatory insufficiency.

Authors: 
Journal:  Chin Med J (Engl)       Date:  1975-03       Impact factor: 2.628

4.  Experimental investigations on canine endotoxic shock: changes in hemodynamics and involvement of some humoral factors.

Authors:  H Y Guo; R Y Sun
Journal:  Chin Med J (Engl)       Date:  1982-08       Impact factor: 2.628

5.  Hemodynamic studies of the effect of total alkaloids of datura in experimental hemorrhagic shock in dogs.

Authors:  Y M Zeng; N H Liu; Y T Shen; Y F Yang
Journal:  Resuscitation       Date:  1982-06       Impact factor: 5.262

6.  Pancreatic hypoperfusion and the production of a myocardial depressant factor in hemorrhagic shock.

Authors:  A M Lefer; J A Spath
Journal:  Ann Surg       Date:  1974-06       Impact factor: 12.969

7.  Beneficial effect of anisodamine in hemorrhagic shock.

Authors:  J Su; C E Hock; A M Lefer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-04       Impact factor: 3.000

8.  THE ESTIMATION OF CATHEPSIN WITH HEMOGLOBIN AND THE PARTIAL PURIFICATION OF CATHEPSIN.

Authors:  M L Anson
Journal:  J Gen Physiol       Date:  1937-03-20       Impact factor: 4.086

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.